Skip to content

Edwards Lifesciences EW Income Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$1.65B+5.0%$1.57B+1.1%$1.55B+1.4%$1.53B+8.5%$1.41B+1.9%
$362.6M+5.7%$343M-0.6%$345.2M+0.2%$344.4M+14.2%$301.6M+3.2%
$1.29B+4.8%$1.23B+1.5%$1.21B+1.7%$1.19B+6.9%$1.11B+1.6%
78%-0.1pp78.1%+0.4pp77.8%+0.3pp77.5%-1.1pp78.7%-0.3pp
$263.3M-1.6%$267.7M-4.6%$280.7M+1.6%$276.2M+8.5%$254.6M-6.1%
$522.2M-13.4%$602.9M+17.2%$514.6M+2.5%$502M+7.8%$465.7M-5.3%
$477.6M+216%$151.1M-50.8%$307.1M-25.3%$411.2M+4.2%$394.8M+26.3%
29%+19.3pp9.6%-10.1pp19.8%-7.1pp26.8%-1.1pp27.9%+5.4pp
$459M+408%$90.4M-74.1%$348.4M-12.9%$400.2M-7.8%$433.9M+11.2%
$78.3M+199%$26.2M-53.3%$56.1M-12.8%$64.3M-8.5%$70.3M+55.9%
$380.7M+317%$91.2M-68.7%$291.1M-12.6%$333.2M-6.9%$358M-7.2%
23.1%+17.3pp5.8%-12.9pp18.7%-3.0pp21.7%-3.6pp25.3%-2.5pp
$0.66+312%$0.16-68.0%$0.50-10.7%$0.56-8.2%$0.61-6.2%
$518.5M+168%$193.8M-44.0%$346.3M-22.9%$449.3M+4.1%$431.4M+21.5%
31.5%+19.1pp12.3%-10.0pp22.3%-7.0pp29.3%-1.2pp30.5%+4.9pp
$477.6M+216%$151.1M-50.8%$307.1M-25.3%$411.2M+4.2%$394.8M+26.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is Edwards Lifesciences's revenue?
Edwards Lifesciences (EW) generated $6.3B in revenue over the trailing twelve months, up 14.1% year over year.
Is Edwards Lifesciences profitable?
Edwards Lifesciences reported $1.1B in net income over the trailing twelve months, a 17.4% net margin.
What are Edwards Lifesciences's profit margins?
Gross margin is 77.9% and operating margin is 21.4%, with a 17.4% net margin.
What is Edwards Lifesciences's earnings per share?
Edwards Lifesciences's diluted EPS over the trailing twelve months is $1.88.
Where does Edwards Lifesciences's income statement data come from?
Every line is extracted from Edwards Lifesciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.